SD 1008

Modify Date: 2024-01-09 12:29:15

SD 1008 Structure
SD 1008 structure
Common Name SD 1008
CAS Number 960201-81-4 Molecular Weight 329.35
Density N/A Boiling Point N/A
Molecular Formula C18H19NO5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SD 1008


SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].

 Names

Name Dimethyl (1R,5R,6R,7S)-8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-en e-6,7-dicarboxylate-dimethyl (1S,5S,6S,7R)-8-benzyl-4-oxo-8-aza bicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate (1:1)

 SD 1008 Biological Activity

Description SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].
Related Catalog
Target

JAK2

STAT3

References

[1]. Duan Z, et al. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells. Mol Pharmacol. 2007;72(5):1137-1145.

 Chemical & Physical Properties

Molecular Formula C18H19NO5
Molecular Weight 329.35
Exact Mass 658.25300
PSA 145.82000
LogP 1.78920